Mahesh Iyer - GAIL (India) Director Marketing
| GAILF Stock | USD 16.57 0.00 0.00% |
Insider
Mahesh Iyer is Director Marketing of GAIL Limited
| Age | 59 |
| Phone | 91 11 2618 2955 |
| Web | https://www.gailonline.com |
GAIL (India) Management Efficiency
The company has return on total asset (ROA) of 0.0826 % which means that it generated a profit of $0.0826 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1875 %, meaning that it generated $0.1875 on every $100 dollars invested by stockholders. GAIL (India)'s management efficiency ratios could be used to measure how well GAIL (India) manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Timothy Gray | Anterix | 54 | |
| Ryan Gerbrandt | Anterix | 46 | |
| Tia Bush | Centessa Pharmaceuticals PLC | 53 | |
| A MBA | Cumberland Pharmaceuticals | 66 | |
| Matthew Cooley | Lifevantage | 51 | |
| Golnar Khosrowshahi | Reservoir Media | 53 | |
| Sarah Luna | Xponential Fitness | 37 | |
| MD MSc | Centessa Pharmaceuticals PLC | 64 | |
| Saurabh MD | Centessa Pharmaceuticals PLC | 48 | |
| Iqbal LLB | Centessa Pharmaceuticals PLC | 43 | |
| Eugene Quast | Natural Alternatives Internatio | 65 | |
| Carlos LAbbate | Anterix | N/A | |
| Chelsea Grayson | Xponential Fitness | 49 | |
| Carl Aure | Lifevantage | 50 | |
| Karen Anderson | Centessa Pharmaceuticals PLC | 56 | |
| Joshua MBA | Centessa Pharmaceuticals PLC | 50 | |
| Mark JD | Natural Alternatives Internatio | 70 | |
| David Chao | Centessa Pharmaceuticals PLC | 56 | |
| Gretchen Starcher | Anterix | N/A | |
| Chris Taylor | Lifevantage | N/A | |
| David Grainger | Centessa Pharmaceuticals PLC | 55 | |
Management Performance
| Return On Equity | 0.19 | |||
| Return On Asset | 0.0826 |
GAIL Limited Leadership Team
Elected by the shareholders, the GAIL (India)'s board of directors comprises two types of representatives: GAIL (India) inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GAIL. The board's role is to monitor GAIL (India)'s management team and ensure that shareholders' interests are well served. GAIL (India)'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GAIL (India)'s outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sandeep Gupta, MD Chairman | ||
| Ram Shanker, Chief HR | ||
| Mahesh Agarwal, Company Officer | ||
| A Sahni, Gen Accounts | ||
| Ayush Gupta, Director Director | ||
| Vandana Chanana, Exec CSR | ||
| Mahesh Iyer, Director Marketing | ||
| Rakesh Jain, Director CFO | ||
| S Roy, Chief Security | ||
| Deepak Gupta, Director Director |
GAIL Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is GAIL (India) a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.19 | |||
| Return On Asset | 0.0826 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 8.61 B | |||
| Shares Outstanding | 1.1 B | |||
| Shares Owned By Institutions | 0.09 % | |||
| Price To Earning | 7.35 X | |||
| Price To Book | 1.00 X | |||
| Price To Sales | 0.01 X |
Currently Active Assets on Macroaxis
Other Information on Investing in GAIL Pink Sheet
GAIL (India) financial ratios help investors to determine whether GAIL Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GAIL with respect to the benefits of owning GAIL (India) security.